Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Noxopharm Ltd. ( (AU:NOX) ) is now available.
Noxopharm has detailed changes in director interests following the resignation of Managing Director and CEO Dr Gisela Mautner on 14 April 2026, including the lodgement of a Final Director’s Interest Notice and a delayed Change of Director’s Interest Notice related to unlisted options that lapsed in November 2024. The company attributed the late Appendix 3Y filing to an administrative oversight, outlined its existing compliance framework under ASX Listing Rules, and said it is tightening internal reconciliations between registry, financial records and market releases, while also noting shareholder-approved but yet-to-be-issued loan funded shares that may be allotted to Dr Mautner or her nominee within three years of the 2024 AGM.
Noxopharm’s disclosure underscores its efforts to reinforce governance and continuous disclosure practices at a time of leadership transition, aiming to reassure investors and regulators about its adherence to ASX requirements. The clarification that Dr Mautner held no other securities at resignation, aside from the potential future issue of approved loan funded shares, helps provide transparency over director holdings and may reduce uncertainty for shareholders monitoring board and management changes.
More about Noxopharm Ltd.
Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company focused on discovering and developing novel treatments for cancer and inflammation, including technology designed to improve the safety profile of mRNA medicines. It leverages in-house capabilities and partnerships to build a pipeline of proprietary drugs based on its Sofra platform, targeting inflammation, autoimmunity, mRNA enhancement and oncology, and its Chroma platform, focused on oncology.
Average Trading Volume: 183,166
Technical Sentiment Signal: Sell
Current Market Cap: A$19.66M
For an in-depth examination of NOX stock, go to TipRanks’ Overview page.